Particularly, the study of prostate cancer tissue in patients undergoing ADT showed that after therapy in the tumoral tissue an increase of CD133+/CD44+/CK5+ cells was observed, concomitantly with a decrease of CK8+ cells [624]. This evidence concerns the gene PROM1 and prostate carcinoma.